Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer
1976963 citationsGianni Bonadonna, Pinuccia Valagussa et al.profile →
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION
1989588 citationsMarco Bregni, Salvatore Siena et al.profile →
Dose-Response Effect of Adjuvant Chemotherapy in Breast Cancer
Countries citing papers authored by Gianni Bonadonna
Since
Specialization
Citations
This map shows the geographic impact of Gianni Bonadonna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianni Bonadonna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianni Bonadonna more than expected).
Fields of papers citing papers by Gianni Bonadonna
This network shows the impact of papers produced by Gianni Bonadonna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianni Bonadonna. The network helps show where Gianni Bonadonna may publish in the future.
Co-authorship network of co-authors of Gianni Bonadonna
This figure shows the co-authorship network connecting the top 25 collaborators of Gianni Bonadonna.
A scholar is included among the top collaborators of Gianni Bonadonna based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Gianni Bonadonna. Gianni Bonadonna is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Gelber, Richard D., Bernard F. Cole, Aron Goldhirsch, et al.. (1995). Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival. Cancer Discovery. 1(2). 114–121.3 indexed citations
3.
Gianni, A. M., et al.. (1991). IMPIEGO CLINICO DEI FATTORI DI CRESCITA EMOPOIETICI. Haematologica. 76. 3–10.1 indexed citations
4.
Siena, Salvatore, Marco Bregni, Bruno Brando, et al.. (1991). Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation: comparative analysis of different CD34 monoclonal antibodies.. PubMed. 76(4). 330–3.36 indexed citations
Bonadonna, Gianni, et al.. (1988). Handbook of medical oncology.20 indexed citations
7.
Gaglio, Salvatore, M. Genovesi, C. Ruggiero, et al.. (1987). Expert systems for cancer chemotherapy. Computers & Mathematics with Applications. 14(9-12). 793–802.6 indexed citations
8.
Siena, Salvatore, S. Villà, Gianni Bonadonna, Marco Bregni, & Gianni Am. (1987). Ex vivo depletion of human bone marrow T lymphocytes by soybean lectin fractionation followed by treatment with an anti-pan-T cell (CD5) ricin A- chain immunotoxin.. PubMed. 19(1 Pt 3). 2735–7.1 indexed citations
Bonadonna, Gianni, Armando Santoro, R Zucali, & Pinuccia Valagussa. (1979). Improved 5-year survival in advanced Hodgkin's disease by combined modality approach. 2(3). 217–226.16 indexed citations
11.
Solero, C. L., S. Monfardini, C Brambilla, et al.. (1979). Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 2(1). 43–8.43 indexed citations
12.
Bonadonna, Gianni, Anna Rossi, Pinuccia Valagussa, & Umberto Veronesi. (1978). Actual data on efficacy of surgical adjuvant chemotherapy with CMF in breast cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 48(7). 659–659.1 indexed citations
13.
Santoro, Armando, R Zucali, F Volterrani, & Gianni Bonadonna. (1977). Combined chemotherapy-radiotherapy approach in stages IIB, IIIA and IIIB Hodgkin's disease. Cancer Immunology Immunotherapy. 3.4 indexed citations
14.
Rossi, A., Pinuccia Valagussa, & Gianni Bonadonna. (1977). Surgery and adjuvant chemotherapy in the treatment of operable breast cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 12. 391–404.1 indexed citations
15.
Monfardini, S., Vittorio Fossati, Giorgio Pizzocaro, & Gianni Bonadonna. (1976). STUDIO PILOTA CON DUE ASSOCIAZIONI CHEMIOTERAPICHE NEI CARCINOMI TESTICOLARI. Tumori. 62(4). 435–444.
Bonadonna, Gianni, M. De Lena, A Lattuada, et al.. (1975). Combination chemotherapy and radiotherapy in non-Hodgkin's lymphomata.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 2. 481–8.15 indexed citations
Bonadonna, Gianni, et al.. (1965). PROPOSTA DI CLASSIFICAZIONE E TERAPIA DELLA MALATTIA DI HODGKIN.. Tumori. 51. 97–112.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.